Of interest to the hemp, CBD and cannabis industries, the US House Democratic leaders have decided to postpone voting on legislation to decriminalize marijuana at the federal level until after the November 3, 2020 election. EAS team of consultants, under leadership of Senior Director Tara Lin Couch, Ph.D. are closely monitoring these and all developments in FDA and USDA regulated industries.
In the meantime, those working in this space are encouraged to consider implementing quality systems, or Good Manufacturing Practices (GMPs) for the production of such products. EAS is offering a short course covering the basics of GMP design from the lens of the hemp and CBD industries. Join noted expert, Charlotte Peyton on December 2-3, 2020 for Developing Quality Systems for the Hemp and CBD Industry. You may register here.
For more regulatory information on hemp, CBD and cannabis, including our latest articles found on the EAS website, click here.